CN Patent

CN115724781A — 一种合成乌帕替尼关键手性中间体的方法

Assigned to Shenzhen Catalys Technology Co Ltd · Expires 2023-03-03 · 3y expired

What this patent protects

Patent listed against Rinvoq.

Drugs covered by this patent

Patent Metadata

Patent number
CN115724781A
Jurisdiction
CN
Classification
—
Expires
2023-03-03
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Catalys Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.